✦ LIBER ✦

Medullary carcinoma with lymphocytic infiltration of the stomach. Clinicopathologic study of 27 cases and immunohistochemical analysis of the subpopulations of infiltrating lymphocytes in the tumor

✍ Scribed by Toshinari Minamoto; Masayoshi Mai; Kishichiro Watanabe; Akishi Ooi; Tokuji Kitamura; Yutaka Takahashi; Hiroshi Ueda; Tomomi Ogino; Isao Nakanishi

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 964 KB
Volume: 66
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900901)66:5<945::aid-cncr2820660523>3.0.co;2-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infiltrating lobular carcinoma of the br

Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns

✍ Xavier Sastre-Garau; Michel Jouve; Bernard Asselain; Anne Vincent-Salomon; Phili 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 669 KB

## BACKGROUND. The clinicopathologic features of infiltrating lobular carcinoma (ILC), which represents 5% to 15% of all breast cancers, are still controversial. In particular, the high frequency of multicentric lesions has led to questioning of the effectiveness of conservative treatment for this

Restriction of the T-cell repertoire in

Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions

✍ Isabelle Puisieux; Christine Bain; Yacine Merrouche; Philippe Malacher; Philippe 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 766 KB

## Renal-cell carcinoma (RCC ) is one of the human cancers which respond best to immunotherapy. To better characterize the mechanism of the immune response in RCC, we analyzed the T-cell receptor (TCR) p-chain repertoire in primary RCC, metastases and paired peripheral blood lymphocytes (PBL) from

A randomized trial of adoptive immunothe

A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung cancer

✍ Giovanni B. Ratto; Paolo Zino; Sandro Mirabelli; Paolo Minuti; Riccardo Aquilina 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 750 KB

A previous pilot study from our group suggested that: (1) adoptive immunotherapy (AI) with tumor-infiltrating lymphocytes (TIL) and recombinant interleukin-2 (rIL-2) may be applied with safety to more than 80% of the patients who had surgery for Stage 111 nonsmall cell lung carcinoma (NSCLC); and (2

Favorable outcome in clinically stage II

Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression

✍ Inge S. van Houdt; Berbel J.R. Sluijter; Laura M. Moesbergen; Wim M. Vos; Tanja 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 296 KB 👁 1 views

## Abstract In this study we investigated whether the presence of specific populations of tumor infiltrating lymphocytes (TILs) in diagnostic primary melanoma biopsies are related to outcome in clinically stage II melanoma patients. Moreover, we investigated whether the presence of TILs correlates